These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 22204486)

  • 1. Recent developments in potential anxiolytic agents targeting GABAA/BzR complex or the translocator protein (18kDa) (TSPO).
    Nothdurfter C; Rupprecht R; Rammes G
    Curr Top Med Chem; 2012; 12(4):360-70. PubMed ID: 22204486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medicinal chemistry of indolylglyoxylamide TSPO high affinity ligands with anxiolytic-like effects.
    Simorini F; Marini AM; Taliani S; La Motta C; Salerno S; Pugliesi I; Da Settimo F
    Curr Top Med Chem; 2012; 12(4):333-51. PubMed ID: 22204487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medicinal chemistry of indolylglyoxylamide GABAA/BzR high affinity ligands: identification of novel anxiolytic/non sedative agents.
    Salerno S; Da Settimo F; Taliani S; Simorini F; La Motta C; Fornaciari G; Marini AM
    Curr Top Med Chem; 2012; 12(4):286-311. PubMed ID: 22204484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Translocator protein (18 kDa) as a target for novel anxiolytics with a favourable side-effect profile.
    Nothdurfter C; Rammes G; Baghai TC; Schüle C; Schumacher M; Papadopoulos V; Rupprecht R
    J Neuroendocrinol; 2012 Jan; 24(1):82-92. PubMed ID: 21609361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Translocator protein ligands as promising therapeutic tools for anxiety disorders.
    Taliani S; Da Settimo F; Da Pozzo E; Chelli B; Martini C
    Curr Med Chem; 2009; 16(26):3359-80. PubMed ID: 19548867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Translocator protein as a promising target for novel anxiolytics.
    Costa B; Da Pozzo E; Martini C
    Curr Top Med Chem; 2012; 12(4):270-85. PubMed ID: 22204481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Translocator protein (18kDa) TSPO: a new diagnostic or therapeutic target for stress-related disorders?
    Rupprecht R; Wetzel CH; Dorostkar M; Herms J; Albert NL; Schwarzbach J; Schumacher M; Neumann ID
    Mol Psychiatry; 2022 Jul; 27(7):2918-2926. PubMed ID: 35444254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anxiolytic properties of a 2-phenylindolglyoxylamide TSPO ligand: Stimulation of in vitro neurosteroid production affecting GABAA receptor activity.
    Costa B; Da Pozzo E; Chelli B; Simola N; Morelli M; Luisi M; Maccheroni M; Taliani S; Simorini F; Da Settimo F; Martini C
    Psychoneuroendocrinology; 2011 May; 36(4):463-72. PubMed ID: 20728278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The GABAA-BZR complex as target for the development of anxiolytic drugs.
    Trincavelli ML; Da Pozzo E; Daniele S; Martini C
    Curr Top Med Chem; 2012; 12(4):254-69. PubMed ID: 22204488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurosteroids and translocator protein 18 kDa (TSPO) in depression: implications for synaptic plasticity, cognition, and treatment options.
    Rupprecht R; Pradhan AK; Kufner M; Brunner LM; Nothdurfter C; Wein S; Schwarzbach J; Puig X; Rupprecht C; Rammes G
    Eur Arch Psychiatry Clin Neurosci; 2023 Oct; 273(7):1477-1487. PubMed ID: 36574032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroactive steroids in affective disorders: target for novel antidepressant or anxiolytic drugs?
    Schüle C; Eser D; Baghai TC; Nothdurfter C; Kessler JS; Rupprecht R
    Neuroscience; 2011 Sep; 191():55-77. PubMed ID: 21439354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Translocator protein (18 kDa) (TSPO) as a therapeutic target for anxiety and neurologic disorders.
    Nothdurfter C; Baghai TC; Schüle C; Rupprecht R
    Eur Arch Psychiatry Clin Neurosci; 2012 Nov; 262 Suppl 2():S107-12. PubMed ID: 22923187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GABAA receptors as targets for novel anxiolytic drugs.
    Rupprecht R; Eser D; Zwanzger P; Möller HJ
    World J Biol Psychiatry; 2006; 7(4):231-7. PubMed ID: 17071543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, Synthesis and Anxiolytic Activity Evaluation of N-Acyltryptophanyl- Containing Dipeptides, Potential TSPO Ligands.
    Gudasheva TA; Deeva OA; Mokrov GV; Dyabina AS; Yarkova MA; Seredenin SB
    Med Chem; 2019; 15(4):383-399. PubMed ID: 30457052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ligands for the benzodiazepine binding site--a survey.
    Teuber L; Wätjens F; Jensen LH
    Curr Pharm Des; 1999 May; 5(5):317-43. PubMed ID: 10213798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computational studies on translocator protein (TSPO) and its ligands.
    Ortore G; Tuccinardi T; Martinelli A
    Curr Top Med Chem; 2012; 12(4):352-9. PubMed ID: 22204485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancing neurosteroid synthesis--relationship to the pharmacology of translocator protein (18 kDa) (TSPO) ligands and benzodiazepines.
    Wolf L; Bauer A; Melchner D; Hallof-Buestrich H; Stoertebecker P; Haen E; Kreutz M; Sarubin N; Milenkovic VM; Wetzel CH; Rupprecht R; Nothdurfter C
    Pharmacopsychiatry; 2015 Mar; 48(2):72-7. PubMed ID: 25654303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurosteroids as neuromodulators in the treatment of anxiety disorders.
    Longone P; di Michele F; D'Agati E; Romeo E; Pasini A; Rupprecht R
    Front Endocrinol (Lausanne); 2011; 2():55. PubMed ID: 22654814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repeated administration of AC-5216, a ligand for the 18 kDa translocator protein, improves behavioral deficits in a mouse model of post-traumatic stress disorder.
    Qiu ZK; Zhang LM; Zhao N; Chen HX; Zhang YZ; Liu YQ; Mi TY; Zhou WW; Li Y; Yang RF; Xu JP; Li YF
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():40-6. PubMed ID: 23624119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An update into the medicinal chemistry of translocator protein (TSPO) ligands.
    Barresi E; Robello M; Costa B; Da Pozzo E; Baglini E; Salerno S; Da Settimo F; Martini C; Taliani S
    Eur J Med Chem; 2021 Jan; 209():112924. PubMed ID: 33081988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.